Success factors of extracorporeal shock wave lithotripsy for renal and upper ureteric calculi in adults

Author:

Elmasry Hoda A.,Edris Ayman M.,Khalifa Mohammed K.

Abstract

Background Extracorporeal shock wave lithotripsy (ESWL) is considered the first-line treatment for most patients with renal and ureteric calculi, as it is safe and noninvasive. Objective The present study was undertaken to evaluate the most significant factors that influence the success rate of ESWL for renal and upper ureteric calculi in adults. Patients and methods This randomized prospective study for adult patients more than or equal to 18 years old included 50 patients with renal stone less than or equal to 2 cm and 50 patients with upper ureteric stone less than or equal to 2 cm. The included patients were treated with ESWL at Al-Zahraa University Hospital and National Institute of Urology and Nephrology between August 2018 and July 2019. Patients with multiple ipsilateral stones, bleeding disorders, impaired renal function, congenital abnormalities, untreated urinary tract infections, have BMI more than 30 kg/m2, pregnant women, and patients with radiolucent stones were excluded from the study. P value less than or equal to 0.05 was taken as the level of significance. Results The overall success of ESWL was 86 (86%), including 81 (94.2%) patients who had total stone clearance. The other five patients had Steinstrasse after the first session. The success rate of ESWL in males was 92.6% compared with 78.3% in females (P=0.040). The success rate of ESWL in patients with stent was 66.77%, whereas the success rate of ESWL in patients without stent was 90.2%, with P value 0.009. The success rate of ESWL in stone density more than 1000 HU was 80.8%, whereas the success rate of ESWL in stone density less than or equal to 1000 HU was 96.97%, with P value of 0.027. Conclusion ESWL should be considered a first-line therapy for treatment in patients with upper urinary tract calculi with density less than or equal to 1000 HU and size up to 20 mm. Stenting should be considered in certain cases when indicated.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3